Browse > Article
http://dx.doi.org/10.5483/BMBRep.2018.51.2.011

MicroRNAs as critical regulators of the endothelial to mesenchymal transition in vascular biology  

Kim, Jongmin (Cellular Heterogeneity Research Center (CHRC), Sookmyung Women's University)
Publication Information
BMB Reports / v.51, no.2, 2018 , pp. 65-72 More about this Journal
Abstract
The endothelial to mesenchymal transition (EndMT) is a newly recognized, fundamental biological process involved in development and tissue regeneration, as well as pathological processes such as the complications of diabetes, fibrosis and pulmonary arterial hypertension. The EndMT process is tightly controlled by diverse signaling networks, similar to the epithelial to mesenchymal transition. Accumulating evidence suggests that microRNAs (miRNAs) are key regulators of this network, with the capacity to target multiple messenger RNAs involved in the EndMT process as well as in the regulation of disease progression. Thus, it is highly important to understand the molecular basis of miRNA control of EndMT. This review highlights the current fund of knowledge regarding the known links between miRNAs and the EndMT process, with a focus on the mechanism that regulates associated signaling pathways and discusses the potential for the EndMT as a therapeutic target to treat many diseases.
Keywords
Endothelial cell; Endothelial dysfunction; Endothelial to mesenchymal transition; MicroRNA; Vascular disease;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Bijkerk R, de Bruin RG, van Solingen C et al (2012) MicroRNA-155 functions as a negative regulator of RhoA signaling in TGF-beta-induced endothelial to mesenchymal transition. Microrna 1, 2-10   DOI
2 Ruderman NB, Williamson JR and Brownlee M (1992) Glucose and diabetic vascular disease. FASEB J 6, 2905-2914   DOI
3 Cao Y, Feng B, Chen S, Chu Y and Chakrabarti S (2014) Mechanisms of endothelial to mesenchymal transition in the retina in diabetes. Invest Ophthalmol Vis Sci 55, 7321-7331   DOI
4 Feng B, Cao Y, Chen S, Chu X, Chu Y and Chakrabarti S (2016) miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy. Diabetes 65, 768-779   DOI
5 Geng HZ and Guan J (2017) MiR-18a-5p inhibits endothelial mesenchymal transition and cardiac fibrosis through the Notch2 pathway. Biochem Biophys Res Commun 491, 329-336   DOI
6 Kumarswamy R, Volkmann I, Jazbutyte V, Dangwal S, Park DH and Thum T (2012) Transforming Growth Factor-beta-Induced Endothelial-to-Mesenchymal Transition Is Partly Mediated by MicroRNA-21. Arterioscler Thromb Vasc Biol 32, 361-369   DOI
7 Ghosh AK, Nagpal V, Covington JW, Michaels MA and Vaughan DE (2012) Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT. Cell Signal 24, 1031-1036   DOI
8 Suzuki HI, Katsura A, Mihira H, Horie M, Saito A and Miyazono K (2017) Regulation of TGF-beta-mediated endothelial-mesenchymal transition by microRNA-27. J Biochem 161, 417-420   DOI
9 Li L, Kim IK, Chiasson V, Chatterjee P and Gupta S (2017) NF-kappaB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension. Exp Cell Res 359, 235-242   DOI
10 Kendall RT and Feghali-Bostwick CA (2014) Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol 5, 123
11 Zeisberg EM, Tarnavski O, Zeisberg M et al (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13, 952-961   DOI
12 Lin F, Wang N and Zhang TC (2012) The role of endothelial-mesenchymal transition in development and pathological process. IUBMB Life 64, 717-723   DOI
13 Maddaluno L, Rudini N, Cuttano R et al (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498, 492-496   DOI
14 Xu YP, He Q, Shen Z et al (2017) MiR-126a-5p is involved in the hypoxia-induced endothelial-to-mesenchymal transition of neonatal pulmonary hypertension. Hypertens Res 40, 552-561   DOI
15 He M, Chen Z, Martin M et al (2017) miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease. Circ Res 120, 354-365   DOI
16 Guo Y, Li P, Bledsoe G, Yang ZR, Chao L and Chao J (2015) Kallistatin inhibits TGF-beta-induced endothelialmesenchymal transition by differential regulation of microRNA-21 and eNOS expression. Exp Cell Res 337, 103-110   DOI
17 Shen B, Hagiwara M, Yao YY, Chao L and Chao J (2008) Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension 51, 1358-1365   DOI
18 Chen PY, Qin L, Barnes C et al (2012) FGF regulates TGF-beta signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep 2, 1684-1696   DOI
19 Yao Y, Jumabay M, Ly A, Radparvar M, Cubberly MR and Bostrom KI (2013) A role for the endothelium in vascular calcification. Circ Res 113, 495-504   DOI
20 Chen PY, Qin L, Baeyens N et al (2015) Endothelial-tomesenchymal transition drives atherosclerosis progression. J Clin Invest 125, 4514-4528   DOI
21 Potenta S, Zeisberg E and Kalluri R (2008) The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 99, 1375-1379   DOI
22 Kovacic JC, Mercader N, Torres M, Boehm M and Fuster V (2012) Epithelial-to-mesenchymal and endothelial-tomesenchymal transition: from cardiovascular development to disease. Circulation 125, 1795-1808   DOI
23 Lee A, McLean D, Choi J, Kang H, Chang W and Kim J (2014) Therapeutic implications of microRNAs in pulmonary arterial hypertension. BMB Rep 47, 311-317   DOI
24 Kim JD, Lee A, Choi J et al (2015) Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension. Exp Mol Med 47, e175   DOI
25 Nagai T, Kanasaki M, Srivastava SP et al (2014) N-acetylseryl-aspartyl-lysyl-proline inhibits diabetes-associated kidney fibrosis and endothelial-mesenchymal transition. Biomed Res Int 2014, 696475
26 Hobert O (2008) Gene regulation by transcription factors and microRNAs. Science 319, 1785-1786   DOI
27 Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC and Ten Dijke P (2017) TGF-beta-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Int J Mol Sci 18
28 Noseda M, McLean G, Niessen K et al (2004) Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res 94, 910-917   DOI
29 Perez L, Munoz-Durango N, Riedel CA et al (2017) Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions. Cytokine Growth Factor Rev 33, 41-54   DOI
30 Welch-Reardon KM, Wu N and Hughes CC (2015) A role for partial endothelial-mesenchymal transitions in angiogenesis? Arterioscler Thromb Vasc Biol 35, 303-308   DOI
31 Zhang H, Hu J and Liu L (2017) MiR-200a modulates TGF-beta1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs. Biomed Pharmacother 95, 215-222   DOI
32 Korpal M, Lee ES, Hu G and Kang Y (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283, 14910-14914   DOI
33 Correia AC, Moonen JR, Brinker MG and Krenning G (2016) FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-beta signaling. J Cell Sci 129, 569-579   DOI
34 Sun Y, Cai J, Yu S, Chen S, Li F and Fan C (2016) MiR-630 Inhibits Endothelial-Mesenchymal Transition by Targeting Slug in Traumatic Heterotopic Ossification. Sci Rep 6, 22729   DOI
35 Kanasaki K, Shi S, Kanasaki M et al (2014) Linagliptinmediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen. Diabetes 63, 2120-2131   DOI
36 Zhang S, Weinheimer C, Courtois M et al (2003) The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J Clin Invest 111, 833-841   DOI
37 Ramos C, Becerril C, Montano M et al (2010) FGF-1 reverts epithelial-mesenchymal transition induced by TGF-{beta}1 through MAPK/ERK kinase pathway. Am J Physiol Lung Cell Mol Physiol 299, L222-231   DOI
38 Ge S, Xie J, Liu F, He J and He J (2015) MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis models in vivo and in vitro as part of the inhibitory effect of estradiol. J Cell Biochem 116, 2455-2464   DOI
39 Fafeur V, Terman BI, Blum J and Bohlen P (1990) Basic FGF treatment of endothelial cells down-regulates the 85-KDa TGF beta receptor subtype and decreases the growth inhibitory response to TGF-beta 1. Growth Factors 3, 237-245   DOI
40 Papetti M, Shujath J, Riley KN and Herman IM (2003) FGF-2 antagonizes the TGF-beta1-mediated induction of pericyte alpha-smooth muscle actin expression: a role for myf-5 and Smad-mediated signaling pathways. Invest Ophthalmol Vis Sci 44, 4994-5005   DOI
41 Lee JG, Ko MK and Kay EP (2012) Endothelial mesenchymal transformation mediated by IL-1beta-induced FGF-2 in corneal endothelial cells. Exp Eye Res 95, 35-39   DOI
42 Lee HT, Lee JG, Na M and Kay EP (2004) FGF-2 induced by interleukin-1 beta through the action of phosphatidylinositol 3-kinase mediates endothelial mesenchymal transformation in corneal endothelial cells. J Biol Chem 279, 32325-32332   DOI
43 Aird WC (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100, 158-173   DOI
44 Lagendijk AK, Goumans MJ, Burkhard SB et al (2011) MicroRNA-23 restricts cardiac valve formation by inhibiting Has2 and extracellular hyaluronic acid production. Circ Res 109, 649-657   DOI
45 Bayoumi AS, Teoh JP, Aonuma T et al (2017) MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition. Cardiovasc Res 113, 1603-1614   DOI
46 Nakajima Y, Yamagishi T, Hokari S and Nakamura H (2000) Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat Rec 258, 119-127   DOI
47 Michiels C (2003) Endothelial cell functions. J Cell Physiol 196, 430-443   DOI
48 Markwald RR, Fitzharris TP and Smith WN (1975) Sturctural analysis of endocardial cytodifferentiation. Dev Biol 42, 160-180   DOI
49 Armstrong EJ and Bischoff J (2004) Heart valve development: endothelial cell signaling and differentiation. Circ Res 95, 459-470   DOI
50 van Meeteren LA and ten Dijke P (2012) Regulation of endothelial cell plasticity by TGF-beta. Cell Tissue Res 347, 177-186   DOI
51 Krenning G, Zeisberg EM and Kalluri R (2010) The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 225, 631-637   DOI
52 Zeisberg EM, Potenta S, Xie L, Zeisberg M and Kalluri R (2007) Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67, 10123-10128   DOI
53 Ghosh AK, Quaggin SE and Vaughan DE (2013) Molecular basis of organ fibrosis: potential therapeutic approaches. Exp Biol Med (Maywood) 238, 461-481   DOI
54 Arciniegas E, Frid MG, Douglas IS and Stenmark KR (2007) Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 293, L1-L8   DOI
55 Cooley BC, Nevado J, Mellad J et al (2014) TGF-beta signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med 6, 227ra34   DOI